Exome & General Genetics

Code Test Genes TAT
9580 NephrolithiasisNext AGXT, ALPL, APRT, ATP6V0A4, ATP6V1B1, BSND, CA2, CASR, CLCN5, CLDN16, CLDN19, CYP24A1, FAM20A, GRHPR, HOGA1, HPRT1, KCNJ1, MOCOS, OCRL, PRPS1, SLC12A1, SLC22A12, SLC2A9, SLC34A1, SLC34A3, SLC3A1, SLC4A1, SLC7A9, UMOD, XDH 2-4 weeks
9992 ExomeNext-Duo plus mtDNA 4500 6-8 weeks
9991 ExomeNext-Duo 4500 6-8 weeks
9993 ExomeNext-Proband 4500 6-8 weeks
8789 TAADNext ACTA2, BGN, CBS, CHST14, COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, EFEMP2, FBN1, FBN2, FKBP14, FLNA, FOXE3, LOX, MAT2A, MED12, MFAP5, MYH11, MYLK, NOTCH1, PLOD1, PRDM5, PRKG1, SKI, SLC2A10, SMAD3, SMAD4, TGFB2, TGFB3, TGFBR1, TGFBR2, TNXB, ZNF469 14-21 days
9995 ExomeNext-Trio Whole Exome 6-8 weeks
9500 ExomeNext-Select 500 2-4 weeks
9996 ExomeNext-Trio plus mtDNA Whole Exome 6-8 weeks
9994 ExomeNext-Proband plus mtDNA 4500 6-8 weeks
8064 PancNext plus Pancreatitis APC, ATM, BRCA1, BRCA2, CASR, CDKN2A, CFTR, CPA1, CTRC, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, PRSS1, SPINK1, STK11, TP53 14-21 days
9999R ExomeNext-Rapid Whole Exome 8-14 days
5490 SNP Array Whole Genome 14-21 days
8022 Pancreatitis Panel CASR, CFTR, CPA1, CTRC, PRSS1, SPINK1 2-4 weeks
8100 Surfactant Panel ABCA3, SFTPB, SFTPC 5-14 days
8122 PCD Panel ARMC4, CCDC103, CCDC114, CCDC39, CCDC40, CFTR, DNAAF1, DNAAF2, DNAAF3, DNAAF5, DNAH11, DNAH5, DNAI1, DNAI2, LRRC6, NME8, OFD1, RPGR, RSPH4A, RSPH9, SPAG1 4-5 weeks
8140 TERT/TERC seq and del/dup TERC, TERT 2-4 weeks
8161 DCNext seq and del/dup DKC1, NHP2, NOP10, TERC, TERT, TINF2, WRAP53 2-4 weeks
8310 MODY seq and del/dup GCK, HNF1A, HNF1B, HNF4A, PDX1 4-5 weeks
8402 NoonanNext BRAF, CBL, HRAS, KRAS, LZTR1, MAP2K1, MAP2K2, NF1, NRAS, PPP1CB, PTPN11, RAF1, RASA1, RIT1, SHOC2, SOS1, SOS2, SPRED1 14-21 days
8550 DBANext RPL11, RPL19, RPL26, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, RPS7 2-4 weeks
8604 BMPR1A & SMAD4 seq and del/dup BMPR1A, SMAD4 14-21 days
8672 HHTNext ACVRL1, ENG, EPHB4, GDF2, RASA1, SMAD4 14-21 days
5504 PGLNext® EGLN1, FH, KIF1B, MAX, MEN1, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL 14-21 days
5704 NF1 seq and del/dup NF1 14-21 days
6301 FH seq and del/dup FH 14-21 days
1007 CFTR seq and del/dup CFTR 5-13 days
1440 SBDS seq SBDS 2-4 weeks
1580 PHOX2B seq PHOX2B 2-4 weeks
2606 VHL seq and del/dup VHL 14-21 days
2646 MEN1 seq and del/dup MEN1 14-21 days
2680 RET seq
Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC)
 RET-related Hirschsprung disease
 		RET 14-21 days
2766 STK11 seq and del/dup STK11 14-21 days

Please select a category to find your test or learn more about our highlighted tests below

  • Exome & Microarray
    • Testing Options
      • Name TAT Genes
        ExomeNext-Proband™ 6-8 weeks ~ 4,500 genes
        ExomeNext-Proband plus mtDNA 6-8 weeks ~ 4,500 genes
        ExomeNext-Duo™ 6-8 weeks ~ 4,500 genes
        ExomeNext-Duo plus mtDNA 6-8 weeks ~ 4,500 genes
        ExomeNext-Trio™ 6-8 weeks ~ 20,000 Genes
        ExomeNext-Trio plus mtDNA 6-8 weeks ~ 20,000 Genes
        ExomeNext-Rapid® 8-14 days ~ 20,000 Genes
        ExomeNext-Select 2-4 weeks up to 500 genes
        SNP Array 14-21 days Whole Genome
  • Endocrinology
    • Testing Options
      • Name TAT Genes
        Hereditary leiomyomatosis and renal cell carcinoma 14-21 days 1
        MODY panel 4-5 weeks 5
        Multiple endocrine neoplasia type 1 14-21 days 1
        Multiple endocrine neoplasia type 2 and familial medullary thyroid cancer 14-21 days 1
        Neurofibromatosis 1 14-21 days 1
        PGLNext® 14-21 days 14
        von Hippel-Lindau disease 14-21 days 1
  • Gastroenterology
    • Testing Options
      • Name TAT Genes
        Cystic fibrosis 5-13 days 1
        RET-related Hirschsprung disease 14-21 days 1
        Juvenile polyposis syndrome 14-21 days 2
        Pancreatitis panel 2-4 weeks 6
        PancNext® plus Pancreatitis 14-21 days 19
        Peutz-Jeghers syndrome 14-21 days 1
  • Multiple Congenital Anomalies
    • Testing Options
      • Name TAT Genes
        SNP Array 14-21 days Whole Genome
        NoonanNext™ 14-21 days 18
  • Hematology
    • Testing Options
      • Name TAT Genes
        DBANext™ 2-4 weeks 11
        DCNext™ 2-4 weeks 7
        Shwachman-Diamond syndrome 2-4 weeks 1
  • Pulmonology
    • Testing Options
      • Name TAT Genes
        Congenital central hypoventilation syndrome 2-4 weeks 1
        Cystic fibrosis 5-13 days 1
        PCDNext® 4-5 weeks 21
        Surfactant dysfunction 5-14 days 3
        Telomere-related pulmonary fibrosis 2-4 weeks 2
  • Vascular
    • Testing Options
      • Name TAT Genes
        HHTNext® 14-21 days 6
        TAADNext® 14-21 days 35
  • Nephrology

why choose ambry

Clearly identifying the genetic cause of a condition allows clinicians to accurately manage a patient’s healthcare as well as provide counseling for the family. That’s why Ambry was the first lab to provide CLIA-approved exome services for applications in clinical diagnostics, with a focus on novel findings. Our clinical genetic and exome testing offer the most comprehensive results in a timely, cost-effective manner using advanced technology and our state of the art bioinformatics pipeline.

Choose from one of our more frequently ordered tests listed below.

ExomeNext®

The world of genetics and our understanding of genetic causes for disease is rapidly changing. ExomeNext is a comprehensive test analyzing all 20,000 genes which has been successful in ending the diagnostic odyssey for 30% of undiagnosed patients. ExomeNext is uniquely positioned to analyze genes that are both related to and outside of the clinician's differential diagnoses.

SNP Array

SNP Array (chromosomal microarray) is useful for identifying slight variation and is recommended as a first-tier genetic test. It is often used in the postnatal evaluation of individuals with multiple congenital anomalies, developmental delay/intellectual disability and autism spectrum disorders. As a cost-effective approach for other diagnoses including chronic kidney disease, congenital heart defects, and infantile spasms, our SNP Array is your first line of defense when it comes to identifying these disorders.

Patients

Providers

Partners

Science

Company

COVID

Search Results

Start your search...